ZA872204B - Etodolac for use in lowering uric acid blood levels - Google Patents

Etodolac for use in lowering uric acid blood levels

Info

Publication number
ZA872204B
ZA872204B ZA872204A ZA872204A ZA872204B ZA 872204 B ZA872204 B ZA 872204B ZA 872204 A ZA872204 A ZA 872204A ZA 872204 A ZA872204 A ZA 872204A ZA 872204 B ZA872204 B ZA 872204B
Authority
ZA
South Africa
Prior art keywords
etodolac
uric acid
blood levels
acid blood
lowering uric
Prior art date
Application number
ZA872204A
Other languages
English (en)
Inventor
John Francis Mullane
Francis Mullane John
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA872204B publication Critical patent/ZA872204B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Luminescent Compositions (AREA)
ZA872204A 1986-04-17 1987-03-25 Etodolac for use in lowering uric acid blood levels ZA872204B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/853,069 US4663345A (en) 1986-04-17 1986-04-17 Etodolac for treatment of gout

Publications (1)

Publication Number Publication Date
ZA872204B true ZA872204B (en) 1988-10-26

Family

ID=25314952

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872204A ZA872204B (en) 1986-04-17 1987-03-25 Etodolac for use in lowering uric acid blood levels

Country Status (11)

Country Link
US (1) US4663345A (cs)
EP (1) EP0245954B1 (cs)
JP (1) JPH0761942B2 (cs)
AT (1) ATE78686T1 (cs)
AU (1) AU600715B2 (cs)
DE (1) DE3780702T2 (cs)
ES (1) ES2043652T3 (cs)
GR (1) GR3005697T3 (cs)
IE (1) IE60179B1 (cs)
PH (1) PH22880A (cs)
ZA (1) ZA872204B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399093B1 (en) 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
IN190974B (cs) 1999-09-10 2003-09-06 Ranbaxy Lab Ltd
CN101641339B (zh) 2007-02-01 2013-07-17 雷斯韦洛吉克斯公司 用于预防和治疗心血管疾病的化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843681A (en) * 1971-06-01 1974-10-22 American Home Prod 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives

Also Published As

Publication number Publication date
GR3005697T3 (cs) 1993-06-07
EP0245954A3 (en) 1990-06-27
DE3780702T2 (de) 1992-12-10
AU600715B2 (en) 1990-08-23
PH22880A (en) 1989-01-19
DE3780702D1 (de) 1992-09-03
AU7119987A (en) 1987-11-05
EP0245954A2 (en) 1987-11-19
ES2043652T3 (es) 1994-01-01
ATE78686T1 (de) 1992-08-15
EP0245954B1 (en) 1992-07-29
IE60179B1 (en) 1994-06-15
JPS62267227A (ja) 1987-11-19
JPH0761942B2 (ja) 1995-07-05
IE870915L (en) 1987-10-17
US4663345A (en) 1987-05-05

Similar Documents

Publication Publication Date Title
EP0214613A3 (en) Method for determination of a differential white blood cell count
PT86298A (en) Method for the treatment of an aqueous medium with copolymers containing acrylamidoalkane sulfonic acid
IE882529L (en) Platinum Coordination Compound
JPS57202303A (en) Enzyme treatment of xanthan gum for improving filtrability of xanthan gum aqueous solution
IL91959A0 (en) Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-1-methoxy carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
ZA878055B (en) A therapeutically useful compound
ZA872204B (en) Etodolac for use in lowering uric acid blood levels
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
PH25421A (en) New furanuronic acid derivatives, method of use thereof
GB2184357B (en) Insert for dental treatment by in-bone implantation
AU2609088A (en) A method of estimating blood cholesterol concentrations
EP0261624A3 (en) Production of microorganisms having ice nucleating activity
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
GB2211411B (en) Organogermanium compounds for improving the reduced function of organs caused by inhibited blood circulation
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
PL257532A1 (en) Method of obtaining novel racemic or optically active derivatives of interfuranyleno-prostacycline
GB8719741D0 (en) Regulating insulin treatment of diabetics
HUT46213A (en) Process for production of medical compounds containing as active substance 3-/4-brome-2-fluor-benzil/-4-oxo-3h-ftalasine 1-il-acetic acid
DE3788035D1 (de) Etodolac zur Hemmung von Gelenkversteifung.
AU591358C (en) Method of treating a patient to inhibit tumor growth
BG49524A1 (en) Method for medical treatment to invalids of myocarditis
BG41533A1 (en) Method for stabilizing of wood
CS1024687A1 (en) Method of peroxide oxygen's polarographical determination
BG49523A1 (en) Method for medical treatment to myocarditis
CS996687A1 (en) Method of bentonite treatment